NVIDIA
NVDA
Tesla
TSLA
Palantir
PLTR
4
BigBear.ai Holdings
BBAI
5
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
SYRE Spyre Therapeutics
- 19.700
- +1.330+7.24%
Close Feb 28 16:00 ET
- 19.700
- 0.0000.00%
Post 20:01 ET
1.19BMarket Cap-6.19P/E (TTM)
19.975High18.380Low652.79KVolume18.690Open18.370Pre Close12.59MTurnover1.40%Turnover RatioLossP/E (Static)60.28MShares47.97052wk High3.28P/B918.43MFloat Cap18.26052wk Low--Dividend TTM46.62MShs Float318.750Historical High--Div YieldTTM8.68%Amplitude2.650Historical Low19.288Avg Price1Lot Size
Spyre Therapeutics News
Spyre Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Spyre Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Spyre Therapeutics | 8-K: Spyre Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Spyre Therapeutics | 10-K: Annual report
Spyre Therapeutics | SCHEDULE 13G/A: Others
Spyre Therapeutics | SCHEDULE 13G/A: Others
Spyre Therapeutics | SCHEDULE 13G/A: Others
Spyre Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burrows Scott L
Spyre Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sloan Sheldon
Spyre Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Turtle Cameron
Spyre Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer King-Jones Heidy
Spyre Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HENDERSON MICHAEL THOMAS
Spyre Therapeutics | 8-K: Current report
Spyre Therapeutics | 8-K: Current report
Spyre Therapeutics | 424B5: Prospectus
Spyre Therapeutics | 424B5: Prospectus
Spyre Therapeutics | 10-Q/A: Quarterly report (Amendment)
Spyre Therapeutics | 10-Q/A: Quarterly report (Amendment)
Spyre Therapeutics | 10-Q/A: Quarterly report (Amendment)
Spyre Therapeutics | 10-K/A: Annual report (Amendment)